Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-11-10 Sale | 2025-11-12 8:36 pm | Lyell Immunopharma Inc. | LYEL | Seely Lynn President and CEO | 412 | $16.11 | $6,637 | 67,159 (Direct) | View |
| 2025-11-10 Sale | 2025-11-12 8:34 pm | Lyell Immunopharma Inc. | LYEL | Bulis Veronica Sanchez VP, Corporate Controller | 239 | $16.1 | $3,848 | 9,213 (Direct) | View |
| 2025-11-10 Sale | 2025-11-12 8:33 pm | Lyell Immunopharma Inc. | LYEL | Lee Gary K. Chief Scientific Officer | 138 | $16.16 | $2,230 | 15,366 (Direct) | View |
| 2025-11-10 Sale | 2025-11-12 8:31 pm | Lyell Immunopharma Inc. | LYEL | Hill Stephen J. Chief Operating Officer | 95 | $16.12 | $1,531 | 15,750 (Direct) | View |
| 2025-08-21 Sale | 2025-08-22 4:07 pm | Lyell Immunopharma Inc. | LYEL | Seely Lynn President and CEO | 7,257 | $10.54 | $76,518 | 67,571 (Direct) | View |
| 2025-08-21 Sale | 2025-08-22 4:06 pm | Lyell Immunopharma Inc. | LYEL | Hill Stephen J. Chief Operating Officer | 1,004 | $10.54 | $10,586 | 15,845 (Direct) | View |
| 2025-08-21 Sale | 2025-08-22 4:03 pm | Lyell Immunopharma Inc. | LYEL | Newton Charles W. Chief Financial Officer | 1,453 | $10.54 | $15,320 | 25,306 (Indirect Direct) | View |
| 2025-08-21 Sale | 2025-08-22 4:02 pm | Lyell Immunopharma Inc. | LYEL | Lee Gary K. Chief Scientific Officer | 1,453 | $10.54 | $15,320 | 15,504 (Direct) | View |
| 2025-08-11 Sale | 2025-08-13 9:10 pm | Lyell Immunopharma Inc. | LYEL | Seely Lynn President and CEO | 797 | $10.43 | $8,313 | 34,828 (Direct) | View |
| 2025-08-11 Sale | 2025-08-13 9:09 pm | Lyell Immunopharma Inc. | LYEL | Hill Stephen J. Chief Operating Officer | 185 | $10.43 | $1,930 | 8,849 (Direct) | View |
| 2025-08-11 Sale | 2025-08-13 9:08 pm | Lyell Immunopharma Inc. | LYEL | Lee Gary K. Chief Scientific Officer | 267 | $10.43 | $2,785 | 8,957 (Direct) | View |
| 2025-08-11 Sale | 2025-08-13 9:06 pm | Lyell Immunopharma Inc. | LYEL | Newton Charles W. Chief Financial Officer | 267 | $10.43 | $2,785 | 18,759 (Indirect Direct) | View |
| 2025-03-31 Purchase | 2025-04-02 3:46 pm | Lyell Immunopharma Inc. | LYEL | BRAWLEY OTIS W Director | 35,640 | $0.56 | $19,958 | 35,640 (Direct) | View |
| 2025-03-21 Purchase | 2025-03-25 6:46 pm | Lyell Immunopharma Inc. | LYEL | Ramachandra Sumant Director | 200,000 | $0.5761 | $115,220 | 200,000 (Indirect) | View |
| 2025-03-14 Purchase | 2025-03-18 8:07 pm | Lyell Immunopharma Inc. | LYEL | Klausner Richard Director | 158,000 | $0.6009 | $94,942 | 3,811,199 (Indirect Direct) | View |
| 2025-03-17 Purchase | 2025-03-18 7:01 pm | Lyell Immunopharma Inc. | LYEL | Newton Charles W. Chief Financial Officer | 200,000 | $0.5581 | $111,620 | 372,725 (Indirect Direct) | View |
| 2025-03-14 Purchase | 2025-03-18 6:59 pm | Lyell Immunopharma Inc. | LYEL | Seely Lynn President and CEO | 175,000 | $0.6068 | $106,190 | 712,500 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2025-11-10 9:07 pm | N/A N/A | Lyell Immunopharma Inc. | LYEL | Bulis Veronica Sanchez VP, Corporate Controller | 0 | $0 | 14,750 (Direct) | View |
| 2025-10-27 Option Award | 2025-10-29 5:42 pm | N/A 2035-10-26 | Lyell Immunopharma Inc. | LYEL | Hill Stephen J. Chief Operating Officer | 75,000 | $0 | 90,845 (Direct) | View |
| 2025-10-27 Option Award | 2025-10-29 5:41 pm | N/A 2035-10-26 | Lyell Immunopharma Inc. | LYEL | Lee Gary K. Chief Scientific Officer | 68,000 | $0 | 83,504 (Direct) | View |
| 2025-10-27 Option Award | 2025-10-29 5:40 pm | N/A 2035-10-26 | Lyell Immunopharma Inc. | LYEL | Seely Lynn President and CEO | 175,000 | $0 | 242,571 (Direct) | View |
| 2025-08-20 Option Award | 2025-08-22 4:07 pm | N/A N/A | Lyell Immunopharma Inc. | LYEL | Seely Lynn President and CEO | 40,000 | $0 | 67,571 (Direct) | View |
| 2025-08-20 Option Award | 2025-08-22 4:06 pm | N/A N/A | Lyell Immunopharma Inc. | LYEL | Hill Stephen J. Chief Operating Officer | 8,000 | $0 | 15,845 (Direct) | View |
| 2025-08-20 Option Award | 2025-08-22 4:03 pm | N/A N/A | Lyell Immunopharma Inc. | LYEL | Newton Charles W. Chief Financial Officer | 8,000 | $0 | 25,306 (Direct) | View |
| 2025-08-20 Option Award | 2025-08-22 4:02 pm | N/A N/A | Lyell Immunopharma Inc. | LYEL | Lee Gary K. Chief Scientific Officer | 8,000 | $0 | 15,504 (Direct) | View |
Ownership | 2025-07-29 9:23 pm | N/A N/A | Lyell Immunopharma Inc. | LYEL | ARCH Venture Fund XIII L.P. ARCH Venture Partners XIII L.P. ARCH Venture Partners XIII LLC CRANDELL KEITH NELSEN ROBERT Burow Kristina GILLIS STEVEN BERNS PAUL L 10% Owner | 0 | $0 | 938,438 (Indirect) | View |
| 2025-06-09 Option Award | 2025-06-11 5:48 pm | N/A 2035-06-08 | Lyell Immunopharma Inc. | LYEL | Bachleda Mark Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2025-06-09 Option Award | 2025-06-11 5:47 pm | N/A 2035-06-08 | Lyell Immunopharma Inc. | LYEL | Meltz Mark A General Counsel | 100,000 | $0 | 100,000 (Direct) | View |
| 2025-06-09 Option Award | 2025-06-11 5:45 pm | N/A 2035-06-08 | Lyell Immunopharma Inc. | LYEL | Shook David Chief Medical Officer | 65,650 | $0 | 65,650 (Direct) | View |
| 2025-05-15 Option Award | 2025-05-19 6:50 pm | N/A 2035-05-14 | Lyell Immunopharma Inc. | LYEL | Klausner Richard Director | 130,000 | $0 | 3,941,199 (Direct) | View |
| 2025-05-15 Option Award | 2025-05-19 6:48 pm | N/A 2035-05-14 | Lyell Immunopharma Inc. | LYEL | RIEFLIN WILLIAM JL Director | 130,000 | $0 | 130,000 (Direct) | View |
| 2025-05-15 Option Award | 2025-05-19 6:47 pm | N/A 2035-05-14 | Lyell Immunopharma Inc. | LYEL | FRIEDMAN CATHY Director | 130,000 | $0 | 466,370 (Direct) | View |
| 2025-05-15 Option Award | 2025-05-19 6:45 pm | N/A 2035-05-14 | Lyell Immunopharma Inc. | LYEL | BRAWLEY OTIS W Director | 130,000 | $0 | 165,640 (Direct) | View |
| 2025-05-15 Option Award | 2025-05-19 6:43 pm | N/A 2035-05-14 | Lyell Immunopharma Inc. | LYEL | NABEL ELIZABETH G Director | 130,000 | $0 | 130,000 (Direct) | View |
| 2025-05-15 Option Award | 2025-05-19 6:41 pm | N/A 2035-05-14 | Lyell Immunopharma Inc. | LYEL | Ramachandra Sumant Director | 130,000 | $0 | 330,000 (Direct) | View |
| 2025-02-10 Option Award | 2025-02-26 7:36 pm | N/A 2035-02-09 | Lyell Immunopharma Inc. | LYEL | Lang Matthew Chief Business Officer | 618,750 | $0 | 668,750 (Direct) | View |
| 2025-02-10 Option Award | 2025-02-26 7:33 pm | N/A 2035-02-09 | Lyell Immunopharma Inc. | LYEL | Seely Lynn President and CEO | 1,856,250 | $0 | 2,056,250 (Direct) | View |
| 2025-02-10 Option Award | 2025-02-26 7:31 pm | N/A 2035-02-09 | Lyell Immunopharma Inc. | LYEL | Hill Stephen J. Chief Operating Officer | 618,750 | $0 | 679,149 (Direct) | View |
| 2025-02-10 Option Award | 2025-02-26 7:29 pm | N/A 2035-02-09 | Lyell Immunopharma Inc. | LYEL | Newton Charles W. Chief Financial Officer | 618,750 | $0 | 678,975 (Direct) | View |
| 2025-02-10 Option Award | 2025-02-26 7:27 pm | N/A 2035-02-09 | Lyell Immunopharma Inc. | LYEL | Lee Gary K. Chief Scientific Officer | 618,750 | $0 | 682,946 (Direct) | View |